Advertisement
Screener

STRONGBRIDGE BIOPHARMA plc General and Administrative Expense

STRONGBRIDGE BIOPHARMA plc General and Administrative Expense

STRONGBRIDGE BIOPHARMA plc reported General and Administrative Expense of $14.88 million for the 12-month period ending 2016-12-31, per its 20-F filed 2017-04-04.

Discontinued › Expense Statement › Operating Expenses

us-gaap:GeneralAndAdministrativeExpense · last filed 2017-04-04

  • STRONGBRIDGE BIOPHARMA plc general and administrative expense for the quarter ending 2016-12-31 was $3.62M, a 20.79% decline year-over-year.
  • STRONGBRIDGE BIOPHARMA plc general and administrative expense for the quarter ending 2016-09-30 was $3.12M, a 43.69% decline year-over-year.
  • STRONGBRIDGE BIOPHARMA plc general and administrative expense for the quarter ending 2016-06-30 was $4.01M, a 57.80% decline year-over-year.
  • STRONGBRIDGE BIOPHARMA plc general and administrative expense for the quarter ending 2016-03-31 was $4.13M, a 32.85% increase year-over-year.
Period endGeneral and Administrative Expense 3 monthGeneral and Administrative Expense 6 monthGeneral and Administrative Expense 9 monthGeneral and Administrative Expense 12 month
2016-12-31$3.62M
derived: 20-F 12 month − 6-K 9 month · filed 2017-04-04
$6.73M
derived: sum of 2 quarters · filed 2017-04-04
$10.75M
derived: sum of 3 quarters · filed 2017-04-04
$14.88M
20-F · filed 2017-04-04
2016-09-30$3.12M
6-K · filed 2016-12-30
$7.13M
derived: sum of 2 quarters · filed 2016-12-30
$11.26M
6-K · filed 2016-12-30
$15.82M
derived: sum of 4 quarters · filed 2017-04-04
2016-06-30$4.01M
6-K · filed 2016-12-30
$8.14M
6-K · filed 2016-12-30
$12.71M
derived: sum of 3 quarters · filed 2017-04-04
$18.24M
derived: sum of 4 quarters · filed 2017-04-04
2016-03-31$4.13M
6-K · filed 2016-05-17
$8.69M
derived: sum of 2 quarters · filed 2017-04-04
$14.23M
derived: sum of 3 quarters · filed 2017-04-04
$23.74M
derived: sum of 4 quarters · filed 2017-04-04
2015-12-31$4.56M
derived: 20-F 12 month − 6-K 9 month · filed 2017-04-04
$10.10M
derived: sum of 2 quarters · filed 2017-04-04
$19.61M
derived: sum of 3 quarters · filed 2017-04-04
$22.72M
20-F · filed 2017-04-04
2015-09-30$5.54M
6-K · filed 2016-12-30
$15.05M
derived: sum of 2 quarters · filed 2016-12-30
$18.16M
6-K · filed 2016-12-30
2015-06-30$9.51M
6-K · filed 2016-12-30
$12.62M
6-K · filed 2016-12-30
2015-03-31$3.11M
6-K · filed 2016-05-17
2014-12-31$4.59M
20-F · filed 2017-04-04
2013-12-31$2.66M
20-F · filed 2016-03-24